Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study

BACKGROUND: Olaparib-induced anemia is a frequently occurring complication in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer and is associated with a marked deterioration in patients’ health-related quality of life. This study aimed to clarify patient-spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashiro, Ryota, Kawazoe, Hitoshi, Mamishin, Kanako, Seto, Keisuke, Udagawa, Ryoko, Saito, Yoshimasa, Hashimoto, Hironobu, Shimoi, Tatsunori, Yonemori, Kan, Yonemura, Masahito, Terakado, Hiroyuki, Kawasaki, Toshikatsu, Furukawa, Tetsuya, Nakamura, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577461/
https://www.ncbi.nlm.nih.gov/pubmed/36267984
http://dx.doi.org/10.3389/fonc.2022.898150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577461/
https://www.ncbi.nlm.nih.gov/pubmed/36267984
http://dx.doi.org/10.3389/fonc.2022.898150

Ejemplares similares